Marathon Capital Management’s Conformis, Inc. Common Stock CFMS Stock Holding History

Marathon Capital Management’s Portfolio CFMS Stock Details CFMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-400	Closed	-$11K	–	234
2021 Q2	$11K	Hold	400	–	–	﹤0.01%	198
2021 Q1	$9K	Hold	400	–	–	﹤0.01%	185
2020 Q4	$6K	Hold	400	–	–	﹤0.01%	158
2020 Q3	$8K	Hold	400	–	–	﹤0.01%	147
2020 Q2	$8K	Hold	400	–	–	﹤0.01%	139
2020 Q1	$6K	Sell	400 -260	-39%	-$6.36K	﹤0.01%	121
2019 Q4	$24K	Buy	660 +260	+65%	+$12.3K	0.01%	139
2019 Q3	$19K	Sell	400 -320	-44%	-$19.2K	0.01%	112
2019 Q2	$78K	Sell	720 -160	-18%	-$13.2K	0.03%	108
2019 Q1	$63K	Sell	880 -80	-8%	-$2.28K	0.03%	105
2018 Q4	$8K	Buy	+960	New	+$16.1K	﹤0.01%	108
2018 Q3	–	Sell	-960	Closed	-$30K	–	127
2018 Q2	$30K	Buy	960 +60	+7%	+$2.07K	0.01%	117
2018 Q1	$32K	Buy	+900	New	+$37.8K	0.01%	108
2017 Q3	–	Sell	-1,139	Closed	-$122K	–	92
2017 Q2	$122K	Sell	1,139 -6,919	-86%	-$831K	0.06%	78
2017 Q1	$1.05M	Buy	+8,058	New	+$1.36M	0.52%	34
2016 Q3	–	Sell	-4,123	Closed	-$828K	–	99
2016 Q2	$724K	Buy	+4,123	New	+$969K	0.37%	38

Other funds holding CFMS

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

GPCM

Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Marathon Capital Management's CFMS Position: Q3 2021 in Review

Marathon Capital Management sold out of Conformis, Inc. Common Stock (CFMS) in Q3 2021, closing a stake of 400 shares — an estimated $11K sold.

Marathon Capital Management first reported a position in CFMS in Q2 2016 and held it in 16 quarters. The position peaked at $1.05M in Q1 2017. 80 funds tracked by Wall St. Rank hold CFMS as of Q3 2021.

Marathon Capital Management reported no remaining Conformis, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Marathon Capital Management sold 400 Conformis, Inc. Common Stock shares in Q3 2021, an estimated $11K.
Marathon Capital Management first reported a position in Conformis, Inc. Common Stock in Q2 2016 and held it in 16 quarters.
Marathon Capital Management's Conformis, Inc. Common Stock position peaked at $1.05M in Q1 2017.
80 funds tracked by Wall St. Rank held Conformis, Inc. Common Stock as of Q3 2021.

Based on Marathon Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.